blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1112354

EP1112354 - NOVEL PROTEIN KINASE MOLECULES AND USES THEREFOR [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  26.03.2010
Database last updated on 25.09.2024
Most recent event   Tooltip26.03.2010Refusal of applicationpublished on 28.04.2010  [2010/17]
Applicant(s)For all designated states
MILLENNIUM PHARMACEUTICALS, INC.
75 Sidney Street Cambridge
Massachusetts 02139 / US
[N/P]
Former [2001/27]For all designated states
Millennium Pharmaceuticals, Inc.
75 Sidney Street
Cambridge, Massachusetts 02139 / US
Inventor(s)01 / ACTON, Susan
42 Munroe Road
Lexington, MA 02421 / US
 [2001/27]
Representative(s)Lock, Graham James, et al
Fry Heath & Spence LLP
Unit A, Faraday Court
Faraday Road
Crawley, West Sussex RH10 9PU / GB
[N/P]
Former [2001/27]Lock, Graham James, et al
Fry Heath & Spence, The Old College, 53 High Street
Horley, Surrey RH6 7BN / GB
Application number, filing date99945606.409.09.1999
[2001/27]
WO1999US20631
Priority number, dateUS19980099657P09.09.1998         Original published format: US 99657 P
US1998016311529.09.1998         Original published format: US 163115
[2001/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0014212
Date:16.03.2000
Language:EN
[2000/11]
Type: A1 Application with search report 
No.:EP1112354
Date:04.07.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 16.03.2000 takes the place of the publication of the European patent application.
[2001/27]
Search report(s)International search report - published on:US16.03.2000
(Supplementary) European search report - dispatched on:EP10.02.2005
ClassificationIPC:C12N1/20, C12N9/12, C07K16/00, C07H21/04, G01N33/53, C12N5/00
[2004/37]
CPC:
G01N33/5005 (EP,US); A61N1/3655 (EP,US); C12N9/1205 (EP,US);
C12Q1/48 (EP,US); C12Q1/485 (EP,US); G01N33/5008 (EP,US);
G01N33/5014 (EP,US); G01N33/502 (EP,US); G01N33/68 (EP,US);
G01N33/6893 (EP,US); A01K2217/05 (EP,US); C07K2319/00 (EP,US);
G01N2500/00 (EP,US); G01N2800/32 (EP,US) (-)
Former IPC [2001/27]C12N15/00, C12N5/00, C12N1/20, C12N9/12, C07K16/00, C07H21/04, G01N33/53
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/27]
TitleGerman:NEUARTIGE PROTEINKINASE MOLEKÜLE SOWIE DEREN VERWENDUNGEN[2001/27]
English:NOVEL PROTEIN KINASE MOLECULES AND USES THEREFOR[2001/27]
French:NOUVELLES MOLECULES DE PROTEINE KINASE ET LEURS UTILISATIONS[2001/27]
Entry into regional phase06.04.2001National basic fee paid 
06.04.2001Search fee paid 
06.04.2001Designation fee(s) paid 
06.04.2001Examination fee paid 
Examination procedure03.04.2000Request for preliminary examination filed
International Preliminary Examining Authority: US
06.04.2001Amendment by applicant (claims and/or description)
06.04.2001Examination requested  [2001/27]
21.08.2006Despatch of a communication from the examining division (Time limit: M04)
30.11.2006Reply to a communication from the examining division
28.02.2008Despatch of a communication from the examining division (Time limit: M06)
05.09.2008Reply to a communication from the examining division
22.10.2009Application refused, date of legal effect [2010/17]
22.10.2009Date of oral proceedings
10.12.2009Despatch of communication that the application is refused, reason: substantive examination [2010/17]
10.12.2009Minutes of oral proceedings despatched
Fees paidRenewal fee
10.09.2001Renewal fee patent year 03
03.09.2002Renewal fee patent year 04
28.08.2003Renewal fee patent year 05
23.09.2004Renewal fee patent year 06
21.09.2005Renewal fee patent year 07
27.09.2006Renewal fee patent year 08
26.09.2007Renewal fee patent year 09
25.09.2008Renewal fee patent year 10
25.09.2009Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]WO9966051  (SUGEN INC [US], et al) [E] 1-24,26 * NEK-5 protein * * sequences 3,4 *;
 [E]WO0022142  (ONYX PHARMA INC [US]) [E] 1-24,26 * figure 2; claim 4 *;
 [T]  - GOTOH ISAMU ET AL, "Identification and characterization of a novel MAP kinase kinase kinase, MLTK", JOURNAL OF BIOLOGICAL CHEMISTRY, (20010209), vol. 276, no. 6, ISSN 0021-9258, pages 4276 - 4286, XP002314957 [T] 1-24,26 * abstract *

DOI:   http://dx.doi.org/10.1074/jbc.M008595200
 [T]  - BLOEM LAURA J ET AL, "Tissue distribution and functional expression of a cDNA encoding a novel mixed lineage kinase", JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, (200109), vol. 33, no. 9, ISSN 0022-2828, pages 1739 - 1750, XP002314958 [T] 1-24,26 * abstract *

DOI:   http://dx.doi.org/10.1006/jmcc.2001.1437
International search[X]WO9811234  (INCYTE PHARMA INC [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.